NewsRoom Articles - Page 33 of 154 - PsychedelicNewsWire (PNW)

MondayMay 01, 2023 2:30 pm

AI in Psychedelic Space Projected to Grow

Numerous studies have shown that psychedelics possess a range of therapeutic benefits that may be useful in treating various conditions. For instance, one study found that administering psilocybin reduced anxiety and depression in patients with cancer. This research also intersects with artificial intelligence (“AI”), as companies involved in the space work toward ensuring therapy centers are safe places to provide psychedelic therapy. The use of artificial intelligence is expected to increase in this field as companies accelerate their research and realize their visions using this technology. Sam Altman, the creator of ChatGPT, is also the chairman of Journey Colab, a…

FridayApr 28, 2023 2:22 pm

Challenges Facing European Psychedelics Industry

Psychedelics are hallucinogenic drugs that induce temporary alterations in mood, perception and mental processes in an individual when ingested. These drugs can occur naturally, such as psilocybin, or be manufactured in a lab, such as LSD, which was first synthesized by Albert Hoffman in 1938. Before psychedelics were classified under Schedule 1 of the 1971 UN Convention on Psychotropic Drugs, the drugs were used to manage various symptoms and psychiatric issues. This classification was brought on mainly by the growing hostility of sociopolitical views regarding the use of drugs as well as the covert and unethical use of said drugs.…

ThursdayApr 27, 2023 2:45 pm

Oregon Officials Announce Approval of First Testing Lab for Psilocybin

Regulators in Oregon recently announced that they have approved a licensed testing lab for psilocybin, the first of its kind in the country. The Oregon Health Authority revealed that the license would be awarded to Rose City Labs. In a press release, Angie Allbee of Oregon Psilocybin Services stated that lab testing ensured correct labeling of the drug’s potency as well as the safety of products. The announcement comes after the Oregon Health Authority granted permission to licensed practitioners to give psilocybin to adults at certain facilities. Officials were responsible for issuance of licenses to manufacture, test and administer psilocybin…

WednesdayApr 26, 2023 11:55 am

New E60 Episode Looks into Psychedelics as Mental Health Treatment for Athletes

The latest episode on ESPN E60 looks at the use of psychedelics in treating mental health conditions for athletes. The episode, titled Peace of Mind, debuted on April 22, 2023, and was directed and produced by Blake Foeman. The segment focuses on sports, healing and the use of alternative medicines, featuring former Canadian professional ice hockey player, Riley Cote, who has been vocal about the benefits of psychedelics. Cote, who was with the Philadelphia Flyers at the time, scored his only goal against the Montreal Canadiens in February 2008. However, he was involved in many physical altercations during games, which…

TuesdayApr 25, 2023 12:26 pm

The US May Soon Approve MDMA Therapy for PTSD Treatment

This year, the U.S. government will decide whether to approve the use of psychedelic drugs such as MDMA for the treatment of a range of mental health conditions. This milestone will not only be significant for patients in need of alternative therapies but also major players in the industry, including the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a nonprofit organization that specializes in research and education on psychedelics. It was founded in 1986 by Rick Doblin, who has spent decades studying whether psychedelics — MDMD in particular — could help treat patients suffering from post-traumatic stress disorder. MDMA, which…

MondayApr 24, 2023 1:52 pm

Review Examines Trials on Use of Psychedelics by Older Adults

Scientists suggest that psychedelics are safe for use by older individuals when administered in a controlled setting. It should be noted that this safety profile hasn’t been confirmed for older individuals with chronic illnesses, including cardiovascular disease. Estimates from the CDC show that roughly 60% of older people suffer from at least two chronic illnesses, with 75% of those aged 60 and above being hypertensive. Experts argue that these health challenges may contraindicate the use of psychedelics by older adults. For their study, the researchers reviewed clinical trials from the last three decades that looked into MDMA and psilocybin-assisted therapies…

FridayApr 21, 2023 3:09 pm

Psychedelics May Help Manage Long COVID-19 Symptoms

We have seen interest in psychedelics increase significantly these last few years, with more studies highlighting the medical benefits these substances possess. Thus far, research has shown that psychedelics such as psilocybin, MDMA and ketamine may help treat mental health conditions, including anxiety, depression, post-traumatic stress disorder and substance-use disorder. Now, researchers believe that these substances may be useful in the management of long COVID-19 symptoms. Individuals with long COVID-19 often present with coronavirus symptoms that may last months or even years after the infection. The most common symptoms of long COVID-19 include feeling short of breath, extreme fatigue, muscle…

ThursdayApr 20, 2023 11:13 am

Psychedelic-Assisted Therapy May Soon Gain Accreditation Standards

As the prevalence of mental health conditions increases, so does interest in new treatments for these disorders. One particular area of interest is psychedelic-assisted psychotherapy, which involves the supervised administration of psychedelic drugs, such as psilocybin and ketamine, in conjunction with therapy. Psychedelics have been used for centuries by Indigenous communities for their spiritual and religious ceremonies. These substances are known to alter an individual’s mood and perception as well as their cognitive processes. This means these treatments possess the potential to make cognitive behavioral therapy and other talk therapies more effective. Given these effects, patients are bound to be…

WednesdayApr 19, 2023 3:32 pm

The Case for Decriminalizing Psychedelics Nationally

Interest in psychedelics has increased these last few years, mainly as a result of numerous studies that have found that the substances possess a range of medical benefits. The decriminalization of psychedelics is also said to benefit society at large, with improvements being seen in public health and wellness. This is backed by findings from a survey done in Portugal, which found a drop in drug-related adverse outcomes and no reported rise in drug use. Portugal decriminalized the private and public use, possession and acquisition of all drugs in 2000 in an effort to reorient policy towards a health-led approach.…

TuesdayApr 18, 2023 1:38 pm

Study Finds DMT May Be Useful in Treatment of MDD

DMT (N,N-Dimethyltryptamine) is a potent hallucinogenic drug that occurs in many plants and animals. It is commonly used as a psychedelic drug and prepared by different cultures for ritual ceremonies as an entheogen. This drug can be ingested, inhaled or injected. A recently concluded trial has found that DMT may be useful in the treatment of major depressive disorder (MDD). Major depressive disorder refers to a mood disorder that causes an individual to lose interest in activities that usually elicit joy; the mood also results in persistent sadness. The study was conducted by Small Pharma, a company focused on the…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000